Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;22(1):13-22.
doi: 10.1007/s11695-011-0530-y.

The influence of laparoscopic sleeve gastrectomy on metabolic syndrome parameters in obese patients in own material

Hady Razak Hady  1 , Jacek Dadan, Magdalena Luba
Affiliations

The influence of laparoscopic sleeve gastrectomy on metabolic syndrome parameters in obese patients in own material

Hady Razak Hady et al. Obes Surg. 2012 Jan.

Abstract

Popularity of laparoscopic sleeve gastrectomy (LSG) has been growing gradually. The aim of this study was to determine changes in metabolic syndrome parameters as well as insulin, total cholesterol, and LDL cholesterol, and to describe the influence of body weight loss on co-morbidities in obese patients after LSG with 1-year follow-up. The material consists of 130 patients who underwent LSG (2007-2010) in order to treat morbid obesity and who had met before the surgery at least three criteria necessary for the diagnosis of metabolic syndrome according to the International Diabetes Federation. The influence of LSG on co-morbidities was also analyzed. During 1-year follow-up after LSG, we obtained a statistically significant decrease in BMI (from 53.18 ± 7.5 kg/m(2) to 31.4 ± 3.75 kg/m(2), p < 0.00001) and a reduction in waist circumference. Twelve months after the surgery, excess weight loss (EWL) was 59.42 ± 7.21% and excess body mass index loss (EBL) was 61.03 ± 6.50%. One year after LSG, the amount of patients with diagnosed metabolic syndrome decreased in 61 patients (53.08%). After 1 year, none of the patients met five criteria of metabolic syndrome. According to efficiency in body mass loss presented by %EWL and %EBL, LSG is gaining approval as a method of obesity and metabolic syndrome treatment, although it is a relatively new procedure. LSG is rather an easy procedure; the time of performance and hospitalization are shorter which entails normalization in all parameters of metabolic syndrome and decreases the percentage of obese patients with metabolic syndrome.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The amount of patients who met three, four, or five criteria for the diagnosis of metabolic syndrome
Fig. 2
Fig. 2
Postoperative changes in BMI in 130 patients at 1-year follow-up
Fig. 3
Fig. 3
Percentage of weight loss (%EWL) after LSG in 130 patients at 1-year follow-up
Fig. 4
Fig. 4
Percentage of BMI decrease (%EBL) after LSG in 130 patients at 1-year follow-up
Fig. 5
Fig. 5
Postoperative changes in waist circumference in 130 patients at 1-year follow-up
Fig. 6
Fig. 6
Postoperative changes in lipid profiles
Fig. 7
Fig. 7
The amount of patients with diagnosed metabolic syndrome (met three, four, or five criteria MS according to IDF) 6 months or 1 year after LSG
See this image and copyright information in PMC

References

    1. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377:557–567. doi: 10.1016/S0140-6736(10)62037-5. - DOI - PMC - PubMed
    1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–1428. doi: 10.1016/S0140-6736(05)66378-7. - DOI - PubMed
    1. Reaven G. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607. doi: 10.2337/diabetes.37.12.1595. - DOI - PubMed
    1. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–194. doi: 10.2337/diacare.14.3.173. - DOI - PubMed
    1. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 1989;149:1514–1520. doi: 10.1001/archinte.1989.00390070054005. - DOI - PubMed

MeSH terms